Lila Sciences Secures $235 Million to Expand AI-Driven Research

Lila Sciences, a biotechnology company, has raised $235 million in a funding round led by Collective Global and Braidwell. This investment elevates the company's valuation to approximately $1.23 billion. The funds will be used to expand Lila's AI science factories, where automated research is conducted by both human researchers and software.

Lila Sciences emerged from stealth mode in March after a $200 million seed round. The company has developed AI trained on academic literature in fields such as materials, chemistry, and life sciences. The new funding will allow Lila to increase the number and size of its facilities, enhancing its ability to develop technologies like novel materials and new drugs.

The company's approach involves creating a feedback loop where research results are fed back into the AI models, potentially speeding up the discovery process. Lila plans to test its AI against human researchers to evaluate the models' performance. The company has already discovered thousands of novel proteins, nucleic acids, chemistries, and materials since its founding in 2023.

The funding round also saw participation from previous investors such as ARK Venture Fund and General Catalyst. Lila Sciences aims to open its platform to external companies by the end of the year, further expanding its impact in the scientific community.